|
|
Blood, 1 December 2003, Vol. 102, No. 12, pp. 4090-4098.
Prepublished online as a Blood First Edition Paper on July 31, 2003; DOI 10.1182/blood-2003-03-0669.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Interleukin-21 inhibits dendritic cell activation and maturation
Katja Brandt,
Silvia Bulfone-Paus,
Donald C. Foster, and
René Rückert
From the Research Center Borstel, Department of Immunology and Cell Biology, Borstel, Germany; and ZymoGenetics Inc, Seattle, WA.
Interleukin 21 (IL-21) is a newly described cytokine with homology to IL-4 and IL-15. They belong to a cytokine family that uses the common chain for signaling but also have their private high-affinity receptors. Since it is well known that IL-4 modulates differentiation and activation of dendritic cells (DCs), we analyzed effects of IL-21 compared with IL-15 on DC differentiation, maturation, and function. Here we show that DCs generated with granulocyte-macrophage colony-stimulating factor (GMCSF) in the presence of IL-21 (IL-21DCs) differentiated into phenotypically and functionally altered DCs characterized by reduced major histocompatibility complex class II (MHCII) expression, high antigen uptake, and low stimulatory capacity for T-cell activation in vitro. Additionally, IL-21DCs completely failed to induce antigen (Ag)-specific T-cell mediated contact hypersensitivity. Furthermore, IL-21 blocked lipopolysaccharide (LPS)-induced activation and maturation of DCs, which was not mediated by release of the anti-inflammatory cytokine IL-10. In contrast, when supplementing GMCSF with IL-15, DCs differentiated into mature antigen-presenting cells (APCs) with low antigen uptake and highly significant increased capacities to stimulate T cells in vitro and in vivo. Taken together, these results identify a dichotomous action of these structurally related cytokines on DCs, establishing IL-21 as inhibitory cytokine on DC activation and IL-15 as potent stimulator of DC function, making both cytokines interesting targets for therapeutic manipulation of DC-induced immune reactions. (Blood. 2003;102: 4090-4098)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G.-Y. Seo, J. Youn, and P.-H. Kim
IL-21 ensures TGF-{beta}1-induced IgA isotype expression in mouse Peyer's patches
J. Leukoc. Biol.,
May 1, 2009;
85(5):
744 - 750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P.R. Sutherland, T. Van Belle, A. L. Wurster, A. Suto, M. Michaud, D. Zhang, M. J. Grusby, and M. von Herrath
Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice
Diabetes,
May 1, 2009;
58(5):
1144 - 1155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Spolski, H.-P. Kim, W. Zhu, D. E. Levy, and W. J. Leonard
IL-21 Mediates Suppressive Effects via Its Induction of IL-10
J. Immunol.,
March 1, 2009;
182(5):
2859 - 2867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Hinrichs, R. Spolski, C. M. Paulos, L. Gattinoni, K. W. Kerstann, D. C. Palmer, C. A. Klebanoff, S. A. Rosenberg, W. J. Leonard, and N. P. Restifo
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Blood,
June 1, 2008;
111(11):
5326 - 5333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A H Sawalha, K M Kaufman, J A Kelly, A J Adler, T Aberle, J Kilpatrick, E K Wakeland, Q-Z Li, A E Wandstrat, D R Karp, et al.
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus
Ann Rheum Dis,
April 1, 2008;
67(4):
458 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Hansen, A. M. Westendorf, S. Reinwald, D. Bruder, S. Deppenmeier, L. Groebe, M. Probst-Kepper, A. D. Gruber, R. Geffers, and J. Buer
Chronic Antigen Stimulation In Vivo Induces a Distinct Population of Antigen-Specific Foxp3 CD25 Regulatory T Cells
J. Immunol.,
December 15, 2007;
179(12):
8059 - 8068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Davis, K. Skak, M. J. Smyth, P. E.G. Kristjansen, D. M. Miller, and P. V. Sivakumar
Interleukin-21 Signaling: Functions in Cancer and Autoimmunity
Clin. Cancer Res.,
December 1, 2007;
13(23):
6926 - 6932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hiromura, T. Kishida, H. Nakano, T. Hama, J. Imanishi, Y. Hisa, and O. Mazda
IL-21 Administration into the Nostril Alleviates Murine Allergic Rhinitis
J. Immunol.,
November 15, 2007;
179(10):
7157 - 7165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Barker, J. G. Parvani, D. Meyer, A. S. Hey, K. Skak, and N. L. Letvin
IL-21 Induces Apoptosis of Antigen-Specific CD8+ T Lymphocytes
J. Immunol.,
September 15, 2007;
179(6):
3596 - 3603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Ostiguy, E.-L. Allard, M. Marquis, J. Leignadier, and N. Labrecque
IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade
J. Leukoc. Biol.,
September 1, 2007;
82(3):
645 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Casey and M. F. Mescher
IL-21 Promotes Differentiation of Naive CD8 T Cells to a Unique Effector Phenotype
J. Immunol.,
June 15, 2007;
178(12):
7640 - 7648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zeng, R. Spolski, E. Casas, W. Zhu, D. E. Levy, and W. J. Leonard
The molecular basis of IL-21-mediated proliferation
Blood,
May 15, 2007;
109(10):
4135 - 4142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bulanova, V. Budagian, E. Duitman, Z. Orinska, H. Krause, R. Ruckert, N. Reiling, and S. Bulfone-Paus
Soluble Interleukin (IL)-15R{alpha} Is Generated by Alternative Splicing or Proteolytic Cleavage and Forms Functional Complexes with IL-15
J. Biol. Chem.,
May 4, 2007;
282(18):
13167 - 13179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Coquet, K. Kyparissoudis, D. G. Pellicci, G. Besra, S. P. Berzins, M. J. Smyth, and D. I. Godfrey
IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine Production
J. Immunol.,
March 1, 2007;
178(5):
2827 - 2834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutella, S. Danese, and G. Leone
Tolerogenic dendritic cells: cytokine modulation comes of age
Blood,
September 1, 2006;
108(5):
1435 - 1440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pelletier and D. Girard
Differential Effects of IL-15 and IL-21 in Myeloid (CD11b+) and Lymphoid (CD11b-) Bone Marrow Cells
J. Immunol.,
July 1, 2006;
177(1):
100 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Strengell, A. Lehtonen, S. Matikainen, and I. Julkunen
IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells
J. Leukoc. Biol.,
June 1, 2006;
79(6):
1279 - 1285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Perez, L. G. Mahaira, P. A. Sotiropoulou, A. D. Gritzapis, E. G. Iliopoulou, D. K. Niarchos, N. T. Cacoullos, Y. G. Kavalakis, A. I. Antsaklis, N. N. Sotiriadou, et al.
Effect of IL-21 on NK cells derived from different umbilical cord blood populations
Int. Immunol.,
January 1, 2006;
18(1):
49 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Budagian, E. Bulanova, Z. Orinska, E. Duitman, K. Brandt, A. Ludwig, D. Hartmann, G. Lemke, P. Saftig, and S. Bulfone-Paus
Soluble Axl Is Generated by ADAM10-Dependent Cleavage and Associates with Gas6 in Mouse Serum
Mol. Cell. Biol.,
November 1, 2005;
25(21):
9324 - 9339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, M. Bleakley, and C. Yee
IL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response
J. Immunol.,
August 15, 2005;
175(4):
2261 - 2269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Alves, F. A. Arosa, and R. A. W. van Lier
IL-21 Sustains CD28 Expression on IL-15-Activated Human Naive CD8+ T Cells
J. Immunol.,
July 15, 2005;
175(2):
755 - 762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ruckert, K. Brandt, A. Braun, H.-G. Hoymann, U. Herz, V. Budagian, H. Durkop, H. Renz, and S. Bulfone-Paus
Blocking IL-15 Prevents the Induction of Allergen-Specific T Cells and Allergic Inflammation In Vivo
J. Immunol.,
May 1, 2005;
174(9):
5507 - 5515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Vollmer, R. Liu, M. Price, S. Rhodes, A. La Cava, and F.-D. Shi
Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen
J. Immunol.,
March 1, 2005;
174(5):
2696 - 2701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pelletier, A. Bouchard, and D. Girard
In Vivo and In Vitro Roles of IL-21 in Inflammation
J. Immunol.,
December 15, 2004;
173(12):
7521 - 7530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Strengell, I. Julkunen, and S. Matikainen
IFN-{alpha} regulates IL-21 and IL-21R expression in human NK and T cells
J. Leukoc. Biol.,
August 1, 2004;
76(2):
416 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Jin, R. Carrio, A. Yu, and T. R. Malek
Distinct Activation Signals Determine whether IL-21 Induces B Cell Costimulation, Growth Arrest, or Bim-Dependent Apoptosis
J. Immunol.,
July 1, 2004;
173(1):
657 - 665.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|